Global Migraine Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Migraine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Migraine market.
Major Players in the Migraine market are:
Amgen Inc
Otsuka Pharmaceutical Co., Ltd.
Aimovig
Eisai Co. Ltd.
Bausch Health Companies Inc
Johnson & Johnson
Glaxosmithkline
Daiichi Sankyo
Pfizer
Eli Lilly and Company
AstraZeneca Plc
Ajovy
Allergan
Abbott Laboratories
On the basis of types, the Migraine market is primarily split into:
Triptans
Ergot Alkaloids
Acetylcholine Inhibitors
NSAIDs
Ditans
CGRP small molecule antagonists
CGRP monoclonal antibodies
Others
On the basis of applications, the market covers:
Hospital-Based Pharmacies
Retail Pharmacies
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Migraine Market Overview
- 1.1 Product Overview and Scope of Migraine Market
- 1.2 Migraine Market Segment by Type
- 1.2.1 Global Migraine Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Migraine Market Segment by Application
- 1.3.1 Migraine Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Migraine Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Migraine (2017-2029)
- 1.5.1 Global Migraine Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Migraine Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Migraine Industry
- 1.7 Impact of Carbon Neutrality on the Migraine Industry
- 2 Migraine Market Upstream and Downstream Analysis
- 2.1 Migraine Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Migraine Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 Amgen Inc
- 3.1.1 Amgen Inc Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Migraine Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Otsuka Pharmaceutical Co., Ltd.
- 3.2.1 Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Migraine Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Aimovig
- 3.3.1 Aimovig Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Migraine Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 Eisai Co. Ltd.
- 3.4.1 Eisai Co. Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Migraine Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 Bausch Health Companies Inc
- 3.5.1 Bausch Health Companies Inc Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Migraine Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 Johnson & Johnson
- 3.6.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Migraine Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 Glaxosmithkline
- 3.7.1 Glaxosmithkline Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Migraine Market Performance (2017-2022)
- 3.7.4 Business Overview
- 3.8 Daiichi Sankyo
- 3.8.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.8.2 Product Profiles, Application and Specification
- 3.8.3 Migraine Market Performance (2017-2022)
- 3.8.4 Business Overview
- 3.9 Pfizer
- 3.9.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.9.2 Product Profiles, Application and Specification
- 3.9.3 Migraine Market Performance (2017-2022)
- 3.9.4 Business Overview
- 3.10 Eli Lilly and Company
- 3.10.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.10.2 Product Profiles, Application and Specification
- 3.10.3 Migraine Market Performance (2017-2022)
- 3.10.4 Business Overview
- 3.11 AstraZeneca Plc
- 3.11.1 AstraZeneca Plc Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.11.2 Product Profiles, Application and Specification
- 3.11.3 Migraine Market Performance (2017-2022)
- 3.11.4 Business Overview
- 3.12 Ajovy
- 3.12.1 Ajovy Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.12.2 Product Profiles, Application and Specification
- 3.12.3 Migraine Market Performance (2017-2022)
- 3.12.4 Business Overview
- 3.13 Allergan
- 3.13.1 Allergan Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.13.2 Product Profiles, Application and Specification
- 3.13.3 Migraine Market Performance (2017-2022)
- 3.13.4 Business Overview
- 3.14 Abbott Laboratories
- 3.14.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.14.2 Product Profiles, Application and Specification
- 3.14.3 Migraine Market Performance (2017-2022)
- 3.14.4 Business Overview
- 4 Global Migraine Market Landscape by Player
- 4.1 Global Migraine Sales and Share by Player (2017-2022)
- 4.2 Global Migraine Revenue and Market Share by Player (2017-2022)
- 4.3 Global Migraine Average Price by Player (2017-2022)
- 4.4 Global Migraine Gross Margin by Player (2017-2022)
- 4.5 Migraine Market Competitive Situation and Trends
- 4.5.1 Migraine Market Concentration Rate
- 4.5.2 Migraine Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Migraine Sales, Revenue, Price Trend by Type
- 5.1 Global Migraine Sales and Market Share by Type (2017-2022)
- 5.2 Global Migraine Revenue and Market Share by Type (2017-2022)
- 5.3 Global Migraine Price by Type (2017-2022)
- 5.4 Global Migraine Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Migraine Sales, Revenue and Growth Rate of Triptans (2017-2022)
- 5.4.2 Global Migraine Sales, Revenue and Growth Rate of Ergot Alkaloids (2017-2022)
- 5.4.3 Global Migraine Sales, Revenue and Growth Rate of Acetylcholine Inhibitors (2017-2022)
- 5.4.4 Global Migraine Sales, Revenue and Growth Rate of NSAIDs (2017-2022)
- 5.4.5 Global Migraine Sales, Revenue and Growth Rate of Ditans (2017-2022)
- 5.4.6 Global Migraine Sales, Revenue and Growth Rate of CGRP small molecule antagonists (2017-2022)
- 5.4.7 Global Migraine Sales, Revenue and Growth Rate of CGRP monoclonal antibodies (2017-2022)
- 5.4.8 Global Migraine Sales, Revenue and Growth Rate of Others (2017-2022)
- 6 Global Migraine Market Analysis by Application
- 6.1 Global Migraine Consumption and Market Share by Application (2017-2022)
- 6.2 Global Migraine Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Migraine Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Migraine Consumption and Growth Rate of Hospital-Based Pharmacies (2017-2022)
- 6.3.2 Global Migraine Consumption and Growth Rate of Retail Pharmacies (2017-2022)
- 6.3.3 Global Migraine Consumption and Growth Rate of Others (2017-2022)
- 7 Global Migraine Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Migraine Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Migraine Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Migraine Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Migraine Market Forecast (2022-2029)
- 8.1 Global Migraine Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Migraine Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Migraine Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Migraine Price and Trend Forecast (2022-2029)
- 8.2 Global Migraine Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Migraine Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Migraine Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Migraine Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Migraine Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Migraine Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Migraine Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Migraine Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Migraine Sales and Revenue Forecast (2022-2029)
- 8.3 Global Migraine Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Migraine Revenue and Growth Rate of Triptans (2022-2029)
- 8.3.2 Global Migraine Revenue and Growth Rate of Ergot Alkaloids (2022-2029)
- 8.3.3 Global Migraine Revenue and Growth Rate of Acetylcholine Inhibitors (2022-2029)
- 8.3.4 Global Migraine Revenue and Growth Rate of NSAIDs (2022-2029)
- 8.3.5 Global Migraine Revenue and Growth Rate of Ditans (2022-2029)
- 8.3.6 Global Migraine Revenue and Growth Rate of CGRP small molecule antagonists (2022-2029)
- 8.3.7 Global Migraine Revenue and Growth Rate of CGRP monoclonal antibodies (2022-2029)
- 8.3.8 Global Migraine Revenue and Growth Rate of Others (2022-2029)
- 8.4 Global Migraine Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Migraine Consumption Value and Growth Rate of Hospital-Based Pharmacies (2022-2029)
- 8.4.2 Global Migraine Consumption Value and Growth Rate of Retail Pharmacies (2022-2029)
- 8.4.3 Global Migraine Consumption Value and Growth Rate of Others (2022-2029)
- 8.5 Migraine Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Migraine Market Drivers Analysis
- 9.2 Migraine Market Restraints and Challenges
- 9.3 Migraine Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Migraine Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Migraine Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Migraine Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook